• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Trialbee & Belong.Life Partner to Increase Clinical Trial Awareness and Enrollment

by Syed Hamza Sohail 08/08/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

–  Trialbee, the global leader in technology-driven patient recruitment for clinical trials, is launching an Omnichannel Network partnership with Belong.Life, a leading global provider of disease-specific AI-powered patient education and support solutions, to identify and connect qualified patients with clinical research.

–  Through this partnership, Trialbee and Belong.Life will streamline the recruitment process and introduce clinical research to millions of patients in Belong’s dedicated communities for oncology, multiple-sclerosis, obesity and more. The goal of this collaboration is to increase trial enrollment by presenting relevant clinical trial opportunities to Belong.Life’s global network of patients seeking education, support, and resources related to their specific conditions.

Transforming Patient Recruitment with Trialbee’s Honey Platform™

Trialbee is redefining the patient recruitment landscape through innovative technology, dedicated people, and a passion for improving clinical trials. The company’s vendor-agnostic Honey Platform™ is a SaaS-based Patient Recruitment Platform (PRP) that centralizes and standardizes all recruitment activities across every source, channel, and partner, from initial interest to enrollment. This platform offers unparalleled transparency, actionable insights, and robust ROI reporting, resulting in higher-quality referrals that reduce site burden.

Key Features and Benefits:

– Comprehensive Patient Tracking: Trialbee Honey™ stands as the industry’s most comprehensive Patient Recruitment Platform, tracking and managing patient journeys from pre-screening through enrollment. Sponsors and partners gain complete visibility into patient activity and the effectiveness of their recruitment efforts, allowing for real-time adjustments and optimization of outreach strategies.

– Omnichannel Network: Trialbee’s Omnichannel Network provides sponsors with a fully integrated patient recruitment solution, offering access to a diverse range of resources, including community engagement organizations, disease-specific communities, pharmacies, and labs—all through a single point of contact. This network significantly reduces administrative costs, saves time, and accelerates the recruitment process.

Enhanced Efficiency and ROI:

By leveraging the Trialbee Honey Platform™, sponsors benefit from seamless pre-screening processes, real-time patient tracking, and comprehensive reporting tools that enhance recruitment efficiency and return on investment. The platform’s ability to provide a centralized view of recruitment activities ensures that sponsors can make data-driven decisions to improve patient recruitment outcomes.

Trialbee’s commitment to revolutionizing patient recruitment through technology and collaboration positions the company as a leader in optimizing clinical trial processes.


“Patients in Belong.Life’s communities are highly engaged, well-informed, and are seeking ways to manage their conditions,” said Maggie Adamski, Vice President, Omnichannel Solutions at Trialbee. “By tapping into the trust and knowledge that Belong.Life has nurtured, we can reach patients where they are and accelerate the development and accessibility of life-changing treatments.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Clinical Trial, Clinical Trial Monitoring, Clinical Trial Recruitment

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Research Report

2026 Best in KLAS Awards: The Full List of Software & Services Winners

Most-Read

The "Platform" Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

The “Platform” Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

Analysis: Oracle Cerner’s Plans for a National EHR

Oracle May Cut 30k Jobs and Sell Cerner to Fund $156B OpenAI Deal

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

Utah Becomes First State to Approve AI System for Prescription Renewals

Utah Becomes First State to Approve AI System for Prescription Renewals

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |